Project Grant R61AA031695

Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $475K
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
The federal Project Grant award of $852,356 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), is funding a randomized controlled trial of a 12-week music training intervention for children with Fetal Alcohol Spectrum Disorder (FASD). The study, titled "The SYNCHRONY Study," aims to evaluate whether music training can improve brain function and targeted skills related to sensory, motor, and cognitive deficits...
The University of Rochester was awarded a $739,041 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) to develop and initiate testing of a scalable person-centered planning (PCP) intervention to support quality of life for adolescents and adults with fetal alcohol spectrum disorders (FASD). This 3-year project, with a start date of September 10, 2025, will leverage implementation science frameworks and social network...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $117,939 Project Grant under the Alcohol Research Programs (CFDA 93.273) to San Diego State University Foundation. This grant will fund a mixed-methods study to identify risk and protective factors related to resilience in families of children with Fetal Alcohol Spectrum Disorders (FASD). The project aims to explore the impact of the postnatal family environment on developmental outcomes for children with prenatal alcohol...
This federal Project Grant award, provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under CFDA 93.273 "Alcohol Research Programs", aims to conduct a multimodal neuroimaging study (fMRI and MEG) on spatial navigation memory deficits in children and adolescents with prenatal alcohol exposure (PAE). The $733,704 grant, awarded on September 1, 2025, will be performed by the Lovelace Biomedical Research Institute in New Mexico and is expected to be completed by June...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $128,481 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of New Mexico Health Sciences Center. The 2.5-year grant, running from Feb 1, 2025 to Aug 31, 2026, will fund research to determine the potential for pharmacological, genetic, or activity-based interventions to restore neurogenesis in a mouse model of fetal alcohol spectrum disorder (FASD). Specifically, the research will test the...
This Project Grant award, funded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports a comprehensive $398,972 study on improving healthcare quality and equity for newborns with prenatal substance exposure. The study, conducted by the University of California, Davis in collaboration with the Better Outcomes through Research for Newborns (BORN) network and the EMPOWER stakeholder group, aims to:...
This Project Grant award of $1,468,446 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports the development and evaluation of the "Building Relationship, Improving Dialogue, and Growing Empathy (BRIDGE)" intervention. The BRIDGE intervention aims to improve shared decision-making and communication for parents of critically ill children under 2...
This Project Grant award of $163,534 from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) aims to implement and study a parent training program for emotion regulation in autistic toddlers within the Part C Early Intervention system. The key objectives are to: Implement an evidence-based parent training program for emotion regulation in toddlers with autism spectrum disorder (ASD) in the Part C Early Intervention system (Aim 1). Examine the impact of family...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), awarded a $800,105 Project Grant to the Rector & Visitors of the University of Virginia (UVA) to optimize a digital intervention for reducing the risk of alcohol-exposed pregnancy (AEP) among Native American women. The project aims to systematically evaluate and tailor the existing CARRII digital intervention for this population, as well as develop and assess the impact of...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), will fund a $711,938 hybrid implementation effectiveness cluster randomized trial of an mHealth intervention called Better Informed Parents Keeping Adolescents Safe from Alcohol (BIPAS). The goal is to expand the reach of the BIPAS program by translating it into Spanish while maintaining fidelity to the key intervention content, and then...

FAMILIES MOVING FORWARD BRIDGES: AN EARLY INTERVENTION ENHANCEMENT FOR INFANTS AND TODDLERS WITH PRENATAL ALCOHOL EXPOSURE WITH OR AT-RISK FOR FETAL ALCOHOL SPECTRUM DISORDERS - PROJECT SUMMARY/ABSTRACT PRENATAL ALCOHOL EXPOSURE (PAE) CAN LEAD TO A FETAL ALCOHOL SPECTRUM DISORDER AND A LIFETIME OF NEURODEVELOPMENTAL DISABILITIES AND PROBLEMS OF DAILY LIVING. EARLY INTERVENTION DURING THE FIRST THREE YEARS OF LIFE HAS THE POTENTIAL TO MITIGATE THE TERATOGENIC EFFECTS OF PAE AT A TIME OF CRITICAL BRAIN DEVELOPMENT. TIMELY EI SUPPORTS YOUNG CHILDREN'S DEVELOPMENT, STRENGTHENS RESPONSIVE PARENTING AND THE EARLY PARENT-CHILD RELATIONSHIP, AND PROVIDES FAMILY RESOURCES THAT CAN REDUCE PARENTING STRESS. EARLY INTERVENTION BY DESIGN AIMS TO INCREASE CRITICAL EARLY LIFE PROTECTIVE FACTORS AND REDUCE SECONDARY DISABILITIES ASSOCIATED WITH THE CASCADE OF COMPLEX LEARNING AND BEHAVIOR PROBLEMS COMMONLY REPORTED AMONG CHILDREN WITH FETAL ALCOHOL SPECTRUM DISORDERS (FASD). YET THERE IS A CONCERNING LACK OF EFFECTIVE, EVIDENCE-BASED PRACTICES FOR THIS VULNERABLE GROUP OF YOUNG CHILDREN AT A CRUCIAL TIME OF CHILD DEVELOPMENT. OUR RESEARCH TEAM HAS DEVELOPED THE FAMILIES MOVING FORWARD (FMF) BRIDGES EARLY INTERVENTION FOR INFANTS AND TODDLERS AFFECTED BY PAE OR WITH FASD AND THEIR CAREGIVERS. THIS INNOVATIVE EARLY INTERVENTION WAS ADAPTED FROM THE SCIENTIFICALLY VALIDATED FAMILIES MOVING FORWARD (FMF) PROGRAM ORIGINALLY DESIGNED AND SHOWN TO BE EFFICACIOUS FOR PRESCHOOL AND SCHOOL-AGED CHILDREN WITH FASD. FMF BRIDGES BLENDS STANDARD FMF APPROACHES THAT ARE FASD-INFORMED WITH THE ESSENTIAL ELEMENTS OF EARLY CHILDHOOD INTERVENTION BEST PRACTICES THAT ARE RELATIONSHIP-BASED, STRENGTHS-BASED, AND FAMILY-CENTERED. THIS STUDY AIMS TO EXAMINE THE FEASIBILITY OF THE FMF BRIDGES EARLY INTERVENTION IN TWO PHASES. IN BOTH PHASES, THE FMF BRIDGES INTERVENTION WILL BE DELIVERED BY TRAINED COMMUNITY EARLY INTERVENTION PROVIDERS IN PARTNERING COMMUNITY-BASED BIRTH TO THREE SETTINGS. PHASE 1 WILL BE A SMALL TRIAL TO EXAMINE IF THE FMF BRIDGES EARLY INTERVENTION IS FEASIBLE TO IMPLEMENT IN THE COMMUNITY SETTINGS FOR WHICH IT WAS DESIGNED. PARTICIPANTS WILL BE 12 CHILDREN, AGES 6-36 MONTHS WITH PAE OR FASD, AND THEIR CAREGIVERS. PHASE 2 WILL EXAMINE THE FEASIBILITY OF A PILOT RANDOMIZED CONTROLLED TRIAL USING METHODS AND INTERVENTION REFINEMENTS INFORMED BY PHASE 1 DATA. THIRTY-SIX CHILDREN, AGES 6-36 MONTHS, AND THEIR CAREGIVERS WILL BE ENROLLED ACROSS THREE PARTICIPATING EARLY INTERVENTION SITES. EIGHTEEN FAMILIES EACH WILL BE RANDOMIZED TO EITHER FMF BRIDGES OR WAITLIST CONTROL CONDITIONS. STUDY RESULTS WILL INFORM A LARGER SCALE CLINICAL TRIAL OF FMF BRIDGES AS AN FASD-INFORMED EARLY INTERVENTION THAT AIMS TO ENHANCE USUAL CARE IN COMMUNITY BIRTH TO THREE SETTINGS FOR THIS VERY VULNERABLE GROUP OF YOUNG CHILDREN.

Posted 8/14/24